CureVac N.V. (CVAC)
Jan 6, 2026 - CVAC was delisted (reason: acquired by BNTX)
4.660
-0.010 (-0.21%)
Inactive · Last trade price on Jan 5, 2026
CureVac Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Revenue Revenue Growth | 70.74 | 535.18 | 53.76 | 67.42 | 102.99 | 48.87 |
Revenue Growth | -86.98% | 895.54% | -20.26% | -34.54% | 110.74% | 180.61% |
Gross Profit Gross Profit Growth | 65.99 | 429.55 | -62.45 | -91.55 | -112.28 | 34.7 |
Operating Income Operating Income Growth | 182.08 | 209.78 | -266.12 | -224.51 | -1,030 | -133.55 |
Net Income Net Income Growth | 128.82 | 162.19 | -260.17 | -249.03 | -411.72 | -129.12 |
Earnings Per Share EPS Growth | 0.80 | 0.72 | -1.18 | -1.32 | -2.21 | -0.98 |
EPS Growth | 94.02% | - | - | - | - | - |
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Belgium Belgium Growth | 519.85 | 47.13 | 62.26 | 74.3 | 8.81 |
Switzerland Switzerland Growth | 12.95 | 5.43 | 3.37 | 0.92 | 0.7 |
Netherlands Netherlands Growth | 2.38 | 1.2 | 1.79 | 1.77 | 2.63 |
Others Others Growth | - | 0.01 | - | - | - |
Total Total Growth | 535.18 | 53.76 | 67.42 | 102.99 | 48.87 |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Investments Cash & Investments Growth | 416.09 | 481.75 | 402.45 | 495.8 | 811.46 | 1,323 |
Total Debt Total Debt Growth | 35.07 | 38.97 | 41.82 | 42.09 | 28.89 | 55.28 |
Net Cash (Debt) Net Cash Growth | 381.02 | 442.78 | 360.63 | 453.71 | 782.57 | 1,267 |
Net Cash Growth | - | 22.78% | -20.52% | -42.02% | -38.25% | - |
Net Cash Per Share Net Cash Per Share Growth | 2.37 | 1.97 | 1.63 | 2.40 | 4.21 | 9.59 |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Cash Flow Operating Cash Flow Growth | -120.14 | 101.85 | -267.89 | -286.18 | -733.13 | 522.4 |
Capital Expenditures CapEx Growth | -3.99 | -14.32 | -52.32 | -88.02 | -124.22 | -36.33 |
Free Cash Flow Free Cash Flow Growth | -124.13 | 87.54 | -320.21 | -374.2 | -857.35 | 486.07 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Gross Margin | 93.29% | 80.26% | -116.17% | -135.79% | -109.02% | 71.00% |
Operating Margin | 257.38% | 39.20% | -495.04% | -333.00% | -1000.44% | -273.27% |
Pretax Margin | 222.50% | 35.67% | -483.59% | -369.56% | -400.52% | -265.70% |
Profit Margin | 182.11% | 30.30% | -483.96% | -369.37% | -399.76% | -264.21% |
FCF Margin | -175.47% | 16.36% | -595.64% | -555.03% | -832.46% | 994.61% |
| Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 21, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
PE Ratio | 4.98 | 4.56 | - | - | - | - |
P/FCF Ratio | - | 8.44 | - | - | - | 24.06 |
PS Ratio | 9.02 | 1.38 | 15.87 | 15.92 | 54.79 | 239.30 |